EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Hyaluronic acid-CD44 signaling defines therapeutic resistance and immunosuppressive microenvironment in peritoneal metastasis of gastric cancer

Junjie Zhao, Chengbo Ji, Jie Sun, Chenyu Tian, Tianyi Cai, Zhaoming Wang, Zhaodong Sun, Bosen Li, Guoxing Ma, Dan Liu, Masami Yamamoto, Tetsuya Tsukamoto und 7 weitere

Journal for ImmunoTherapy of Cancer · 2026

DOI: 10.1136/jitc-2025-014179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2026. Verfasst von Junjie Zhao und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Hyaluronan Receptors, Stomach Neoplasms, Hyaluronic Acid, Peritoneal Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: shanghai Pujiang Program, Project of Science and Technology of Xiamen City, Natural Science Foundation of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Peritoneal metastasis (PM) is one of the most challenging clinical problems in gastric cancer (GC), largely due to its high recurrence rate and poor response to current therapies. Increasing evidence indicates that remodeling of the extracellular matrix (ECM) plays an important role in therapeutic failure. However, how specific stromal–immune interactions contribute to PM heterogeneity and immunotherapy resistance remains unclear. In this study, we investigated how ECM composition—particularly the accumulation of hyaluronic acid (HA)—influences the immune microenvironment and therapeutic responses in GC-associated PM.

Methods

We combined histopathological assessment, analyses of patient-derived specimens, single-cell transcriptomic profiling, and murine models of PM to delineate ECM remodeling patterns and immune cell dynamics in therapy-sensitive and therapy-resistant lesions. In addition, functional assays and pharmacological approaches were used to examine HA–CD44 signaling and its impact on CD4 + T cell differentiation and responsiveness to immune checkpoint blockade.

Results

Therapy-sensitive PM lesions were characterized by enrichment of elastic fibers, whereas therapy-resistant lesions showed collagen accumulation. Notably, HA deposition emerged as a key feature distinguishing these ECM states and was closely associated with differential therapeutic outcomes. Elevated HA levels activated CD44-dependent signaling in CD4 + T cells, driving regulatory T cell (Treg) differentiation through a CD44–IQGAP1–RAC1–SMAD3 signaling pathway and thereby establishing an immunosuppressive microenvironment. Importantly, pharmacological inhibition of CD44 reduced Treg expansion and markedly enhanced the antitumor efficacy of anti-PD-1 therapy in murine PM models.

Conclusions

Our findings identify HA–CD44 signaling as a critical link between ECM remodeling and immune evasion in GC PM. Targeting ECM-driven immunosuppressive mechanisms may represent a promising strategy to overcome therapeutic resistance and improve the efficacy of immunotherapy in this aggressive disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronan ReceptorsStomach NeoplasmsHyaluronic AcidPeritoneal NeoplasmsAnimalsHumansTumor MicroenvironmentMiceSignal TransductionFemaleDrug Resistance, Neoplasm

Stichwörter der Autor:innen

Gastric CancerTumor Microenvironment

Substanzen

Hyaluronan ReceptorsHyaluronic AcidCD44 protein, human

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Gastric Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of General Surgery, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.
  • Laboratory of Physiological Pathology, Nippon Veterinary and Life Science University, Musashino, Tokyo, Japan.
  • Department of Diagnostic Pathology, Fujita Health University School of Medicine Graduate School of Medicine, Toyoake, Aichi, Japan.
  • Department of Clinical Pharmaceutical Sciences, School of Pharmacy and 19 Pharmaceutical Sciences, Hoshi University, Tokyo, Japan.

Förderung

  • shanghai Pujiang Program
  • Project of Science and Technology of Xiamen City
  • Natural Science Foundation of Fujian Province
  • National Natural Science Foundation of China

Zitieren

APA

Zhao, J., Ji, C., Sun, J., Tian, C., Cai, T., Wang, Z., Sun, Z., Li, B., Ma, G., Liu, D., Yamamoto, M., Tsukamoto, T., Nomura, S., Sun, L., Sun, Y., Huang, L., Ruan, Y., Li, H., & Wang, X. (2026). Hyaluronic acid-CD44 signaling defines therapeutic resistance and immunosuppressive microenvironment in peritoneal metastasis of gastric cancer. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2025-014179

Vancouver

Zhao J, Ji C, Sun J, Tian C, Cai T, Wang Z, et al. Hyaluronic acid-CD44 signaling defines therapeutic resistance and immunosuppressive microenvironment in peritoneal metastasis of gastric cancer. Journal for ImmunoTherapy of Cancer. 2026. doi:10.1136/jitc-2025-014179

BibTeX
@article{Zhao2026,
  author = {Zhao, Junjie and Ji, Chengbo and Sun, Jie and Tian, Chenyu and Cai, Tianyi and Wang, Zhaoming and Sun, Zhaodong and Li, Bosen and Ma, Guoxing and Liu, Dan and Yamamoto, Masami and Tsukamoto, Tetsuya and Nomura, Sachiyo and Sun, Liming and Sun, Yihong and Huang, Liyu and Ruan, Yuanyuan and Li, Haojie and Wang, Xuefei},
  title = {Hyaluronic acid-CD44 signaling defines therapeutic resistance and immunosuppressive microenvironment in peritoneal metastasis of gastric cancer},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  doi = {10.1136/jitc-2025-014179}
}
Kostenlos starten →